A phase 3b multicenter, open-label, treatment optimization study of oral asciminib in patients with Chronic Myelogenous Leukemia in Chronic phase (CML-CP) previously treated with 2 or more tyrosine kinase inhibitors
The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP or CTU): Brain Health Support Program Intervention (BHSP)
A Randomized Trial of Doxycycline Chemoprophylaxis for the Prevention of Sexually Transmitted Infections in Gay, Bisexual and Other Men Who Have Sex with Men (gbMSM)
Vancouver, BC – Transformative technology developed by Vancouver Coastal Health Research Institute (VCHRI) researcher Dr. Mads Daugaard at the Vancouver Prostate Centre (VPC) is putting cell analytics into the hands of scientists around the globe. The artificial intelligence (AI)-driven smartphone app SnapCyte produces data used in cell growth medical research at a fraction of the cost and in a more timely manner than current technology.
Statins can prevent heart conditions among patients with chronic kidney disease who have not started dialysis or received a kidney transplant. Yet, new research from Vancouver Coastal Health Research Institute researcher Dr. Hilary Wu indicated that these patients were often not receiving this potentially life-saving medication.
